Celldex Therapeutics Files Prospectus To Offer 10,345,000 Shares Of Common Stock

Benzinga Newsdesk www.benzinga.com Neutral 87.0%

Neg 0% Neu 87% Pos 0%

-SEC Filing

Comments

No comments yet. Be the first!